218 related articles for article (PubMed ID: 27566080)
1. RRM1, RRM2 and ERCC2 Gene Polymorphisms in Coronary Artery Disease.
Altinkilic EM; Isbir S; Gormus U; Yilmaz SG; Dalan AB; Duman S; Isbir T
In Vivo; 2016 09-10; 30(5):611-5. PubMed ID: 27566080
[TBL] [Abstract][Full Text] [Related]
2. Investigation of some DNA repair genes association in non small cell lung cancer.
Coskunpinar E; Yildiz P; Aynaci E; Turna A; Musteri Oltulu Y; Hekimoglu E; Isbir T; Yaylim I
Cell Mol Biol (Noisy-le-grand); 2015 Dec; 61(8):57-62. PubMed ID: 26718430
[TBL] [Abstract][Full Text] [Related]
3. Genetic variability of genes in NER pathway influences the treatment outcome of gastric cancer.
Xue MH; Li GY; Wu XJ; Zhang CX; Zhang CF; Zhu KX
Int J Clin Exp Pathol; 2015; 8(5):5563-9. PubMed ID: 26191265
[TBL] [Abstract][Full Text] [Related]
4. Association of ERCC2 Gene Polymorphisms with Susceptibility to Diffuse Large B-Cell Lymphoma.
Tong Y; Xiang Y; Li B; Bao S; Zhou Y; Yuan W; Ling Y; Hao D; Zhu H; Sun Z
Med Sci Monit; 2018 Oct; 24():7015-7022. PubMed ID: 30279407
[TBL] [Abstract][Full Text] [Related]
5. Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk.
Qian B; Zhang H; Zhang L; Zhou X; Yu H; Chen K
Lung Cancer; 2011 Aug; 73(2):138-46. PubMed ID: 21195504
[TBL] [Abstract][Full Text] [Related]
6. [Association of C1019T polymorphism in the connexin 37 gene and coronary artery disease in Chinese Han population].
Han YL; Xi SY; Zhang XL; Yan CH; Yang Y; Kang J
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(2):100-4. PubMed ID: 17418016
[TBL] [Abstract][Full Text] [Related]
7. Association of single nucleotide polymorphisms of DNA repair genes in NER pathway and susceptibility to pancreatic cancer.
Zhao F; Shang Y; Zeng C; Gao D; Li K
Int J Clin Exp Pathol; 2015; 8(9):11579-86. PubMed ID: 26617894
[TBL] [Abstract][Full Text] [Related]
8. Impact of polymorphism rs7041 and rs4588 of Vitamin D Binding Protein on the extent of coronary artery disease.
Daffara V; Verdoia M; Rolla R; Nardin M; Marino P; Bellomo G; Carriero A; De Luca G;
Nutr Metab Cardiovasc Dis; 2017 Sep; 27(9):775-783. PubMed ID: 28779988
[TBL] [Abstract][Full Text] [Related]
9. Analysis of ERCC2/XPD functional polymorphisms in systemic lupus erythematosus.
Wan L; Lin YJ; Sheu JJ; Huang CM; Tsai Y; Tsai CH; Wong W; Tsai FJ
Int J Immunogenet; 2009 Feb; 36(1):33-7. PubMed ID: 19055600
[TBL] [Abstract][Full Text] [Related]
10. Association of novel gene polymorphisms RRM1 -756T>C and -269 C>A with breast cancer.
Chen DR; Chuang CY; Wu BC; Yang SF; Peng YH; Tsai HT
J Clin Lab Anal; 2014 Jul; 28(4):287-93. PubMed ID: 24578158
[TBL] [Abstract][Full Text] [Related]
11. Association of two Common Single Nucleotide Polymorphisms (+45T/G and +276G/T) of ADIPOQ Gene with Coronary Artery Disease in Type 2 Diabetic Patients.
Mohammadzadeh G; Ghaffari MA; Heibar H; Bazyar M
Iran Biomed J; 2016 Jul; 20(3):152-60. PubMed ID: 26781170
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms of TGFβ-1 and TGFBR2 in relation to coronary artery disease in a Chinese population.
Yang M; Zhu M; Tang L; Zhu H; Lu Y; Xu B; Jiang J; Chen X
Clin Biochem; 2016 Aug; 49(12):873-8. PubMed ID: 27234600
[TBL] [Abstract][Full Text] [Related]
13. Haplotype analysis on relationship of ERCC2 and ERCC3 gene polymorphisms with osteosarcoma risk in Chinese young population.
Xu Q; Zhang Z; Sun W; Hu B
Mamm Genome; 2017 Jun; 28(5-6):227-233. PubMed ID: 28474168
[TBL] [Abstract][Full Text] [Related]
14. Significant association between ERCC2 and MTHR polymorphisms and breast cancer susceptibility in Moroccan population: genotype and haplotype analysis in a case-control study.
Hardi H; Melki R; Boughaleb Z; El Harroudi T; Aissaoui S; Boukhatem N
BMC Cancer; 2018 Mar; 18(1):292. PubMed ID: 29544444
[TBL] [Abstract][Full Text] [Related]
15. Impact of polymorphisms in DNA repair genes XPD, hOGG1 and XRCC4 on colorectal cancer risk in a Chinese Han Population.
Jin D; Zhang M; Hua H
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30429230
[TBL] [Abstract][Full Text] [Related]
16. Association between ERCC2 polymorphisms and glioma risk: a meta-analysis.
Huang LM; Shi X; Yan DF; Zheng M; Deng YJ; Zeng WC; Liu C; Lin XD
Asian Pac J Cancer Prev; 2014; 15(11):4417-22. PubMed ID: 24969862
[TBL] [Abstract][Full Text] [Related]
17. Influence of ABCB-1, ERCC-1 and ERCC-2 gene polymorphisms on response to capecitabine and oxaliplatin (CAPOX) treatment in colorectal cancer (CRC) patients of South India.
Varma A; Mathaiyan J; Shewade D; Dubashi B; Sunitha K
J Clin Pharm Ther; 2020 Aug; 45(4):617-627. PubMed ID: 32399998
[TBL] [Abstract][Full Text] [Related]
18. RRM1 *151A>T, RRM1 -756T>C, and RRM1 -585T>Gis associated with increased susceptibility of lung cancer in Chinese patients.
Xu XL; Zheng J; Mao WM; Ling ZQ
Cancer Med; 2016 Aug; 5(8):2084-90. PubMed ID: 27335251
[TBL] [Abstract][Full Text] [Related]
19. An association of selected ERCC2 and ERCC5 genes polymorphisms, the level of oxidative DNA damage and its repair efficiency with a risk of colorectal cancer in Polish population.
Kabzinski J; Przybylowska K; Dziki L; Dziki A; Majsterek I
Cancer Biomark; 2015; 15(4):413-23. PubMed ID: 25835182
[TBL] [Abstract][Full Text] [Related]
20. P53 suppresses ribonucleotide reductase via inhibiting mTORC1.
He Z; Hu X; Liu W; Dorrance A; Garzon R; Houghton PJ; Shen C
Oncotarget; 2017 Jun; 8(25):41422-41431. PubMed ID: 28507282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
